Opens Life Sciences North American HQ to Accelerate Precision Medicine

Intro of GE press release:

“GE Healthcare’s Life Sciences business, a global provider of technologies and expertise to the biopharmaceutical and life sciences industries, today opened its new 210,000 square-foot North American headquarters in Marlborough, Massachusetts. At full capacity in 2017, it will employ more than 500 scientists and professionals in the Boston area focused on accelerating precision medicine across a portfolio including:

  • Manufacturing technologies for cell and immune therapies that are showing the potential to cure some of the world’s toughest diseases, such as cancer
  • Early stage research tools used to develop the next generation of precision medicines
  • Technologies and consumables for manufacturing vaccines, insulin and the rapidly growing new class of drugs known as biologics
  • Leading-edge contrast agents and nuclear medicine tracers that clinicians use to diagnose disease

The new facility at 100 Results Way will be home to 40,000 square feet of laboratories supporting cell and immune therapy research and development, early stage drug development, biomanufacturing, as well as scientific and medical affairs support.”

Full release

Additional coverage: